Cotecna Group, the Geneva-headquartered provider of Testing, Inspection, and Certification (TIC) services, announced on 16 October 2026 the acquisition of Energon Labs, a cGMP-compliant analytical testing laboratory based in Hyderabad, India.

The deal strengthens Cotecna's global Life Sciences platform and expands its pharmaceutical testing reach across the Pharmaceutical, Biopharmaceutical, Medical Device and Packaging sectors.

Energon Labs brings USFDA inspection history and dual certifications

Energon Labs is a USFDA-inspected laboratory holding ISO 9001:2015 and ISO 17025:2017 certifications.

The company serves customers across India, the United States, Asia-Pacific, and the Middle East and is recognized for its scientific excellence, regulatory expertise, and commitment to quality.

Hyderabad location ties into global pharmaceutical ecosystem

Hyderabad is one of the world's leading pharmaceutical and biotechnology hubs, and Cotecna stated that the acquisition provides access to highly specialized scientific talent, advanced laboratory infrastructure, and a well-established pharmaceutical ecosystem.

India is described as one of the world's fastest-growing pharmaceutical markets and a critical manufacturing hub for global healthcare supply chains.

According to the announcement, the acquisition enhances Cotecna's ability to support both Indian and international customers with high-quality, regulatory-compliant testing services while delivering greater responsiveness, scalability, and operational efficiency across key markets.

Energon's service portfolio spans method development to packaging studies

Energon offers a comprehensive portfolio of analytical testing and quality assurance services, including analytical method development and validation, stability studies, impurity profiling, extractables and leachables, glass delamination studies, peptides and oligonucleotide characterisation, raw material and finished product testing, in-vitro binding studies, packaging compatibility studies, and regulatory support services.

Cotecna said these capabilities will strengthen its position as a trusted partner to pharmaceutical manufacturers serving regulated markets worldwide.

Deal complements existing Cotecna Life Sciences network

The addition of Energon complements Cotecna's existing pharmaceutical testing network, which includes Cotecna Life Sciences, Shiva Analyticals, and Neotron Pharma.

Together, the company said, these capabilities strengthen the Group's ability to support customers throughout the product lifecycle and address evolving global quality, compliance, and regulatory requirements.

Leadership comments highlight India growth ambitions

Sébastien Dannaud, Chief Executive Officer of Cotecna Group, said, "We are pleased to welcome Energon Labs to the Cotecna Group. This acquisition represents another important step to support our ambition to become one of the largest providers of Life Sciences testing services in India and strengthens our position in one of the world's most important pharmaceutical markets."

Amit Chopra, CEO of South Asia and the Middle East at Cotecna Group, welcomed Manikanth Reddy and the Energon Labs team to the group.

He said the acquisition aligns with the company's strategy of building a comprehensive pharmaceutical testing ecosystem across key growth markets, noting that Energon's strong technical capabilities, experienced team, and established customer relationships will enhance Cotecna's ability to serve pharmaceutical, biopharmaceutical, and medical device companies across India and globally.

"Together, we are creating a stronger platform to support the evolving needs of the pharmaceutical and healthcare sectors," Chopra said.

Manikanth Reddy, Founder of Energon, described the deal as opening an exciting new chapter for the laboratory.

He said Energon has focused over the years on building a laboratory recognized for quality, scientific expertise, and reliability, and that becoming part of a global organization like Cotecna provides new opportunities to expand capabilities, strengthen service offerings, and deliver greater value to customers.

Decode India's Chemical Boom Before Your Competitors Do

How can you capitalize on the emerging opportunities in India's chemical sector? In an industry where innovations outpace financial disclosures, seizing the moment is essential.

⁣From groundbreaking research initiatives led by industry leaders to comprehensive consumer insights, every project lifecycle offers valuable prospects for research firms, analysts, and consultants. The real challenge is not the demand but achieving visibility in a rapidly evolving and fragmented market.

The Global Project Tracking (GPT) platform by Blackridge Research simplifies this complexity, providing verified project intelligence across the Indian chemical sector, enabling you to act on opportunities as they arise.

• Upcoming Projects

• Tender Notices

• Contract Awards

• Projects Under Construction

• Completed Projects

Schedule a Free Demo to discover how the Global Project Tracking (GPT) platform by Blackridge Research transforms scattered chemical signals into a strategic advantage.